BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 16210777)

  • 1. Perospirone, a novel antipsychotic drug, inhibits marble-burying behavior via 5-HT1A receptor in mice: implications for obsessive-compulsive disorder.
    Matsushita M; Egashira N; Harada S; Okuno R; Mishima K; Iwasaki K; Nishimura R; Fujiwara M
    J Pharmacol Sci; 2005 Oct; 99(2):154-9. PubMed ID: 16210777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aripiprazole inhibits marble-burying behavior via 5-hydroxytryptamine (5-HT)1A receptor-independent mechanisms.
    Egashira N; Okuno R; Matsushita M; Abe M; Mishima K; Iwasaki K; Nishimura R; Oishi R; Fujiwara M
    Eur J Pharmacol; 2008 Sep; 592(1-3):103-8. PubMed ID: 18644366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antipsychotic drug perospirone: role of serotonin 5-HT1A receptors.
    Hagiwara H; Fujita Y; Ishima T; Kunitachi S; Shirayama Y; Iyo M; Hashimoto K
    Eur Neuropsychopharmacol; 2008 Jun; 18(6):448-54. PubMed ID: 18164909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marble Burying in NMRI Male Mice Is Preferentially Sensitive to Pre- Versus Postsynaptic 5-HT1A Receptor Biased Agonists.
    Depoortere R; Bardin L; Auclair AL; Bruins Slot LA; Newman-Tancredi A
    Pharmacology; 2021; 106(1-2):114-118. PubMed ID: 32950991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antipsychotic trifluoperazine reduces marble-burying behavior in mice via D
    Egashira N; Kubota N; Goto Y; Watanabe T; Kubota K; Katsurabayashi S; Iwasaki K
    Pharmacol Biochem Behav; 2018 Feb; 165():9-13. PubMed ID: 29273456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of serotonin(1A) receptor agonism on antipsychotic drug-induced dopamine release in rat striatum and nucleus accumbens.
    Ichikawa J; Meltzer HY
    Brain Res; 2000 Mar; 858(2):252-63. PubMed ID: 10708676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of psilocybin on marble burying in ICR mice: role of 5-HT1A receptors and implications for the treatment of obsessive-compulsive disorder.
    Singh S; Botvinnik A; Shahar O; Wolf G; Yakobi C; Saban M; Salama A; Lotan A; Lerer B; Lifschytz T
    Transl Psychiatry; 2023 May; 13(1):164. PubMed ID: 37164956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of mood stabilizers on marble-burying behavior in mice: involvement of GABAergic system.
    Egashira N; Abe M; Shirakawa A; Niki T; Mishima K; Iwasaki K; Oishi R; Fujiwara M
    Psychopharmacology (Berl); 2013 Mar; 226(2):295-305. PubMed ID: 23086022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of antipsychotics and reference monoaminergic ligands on marble burying behavior in mice.
    Bruins Slot LA; Bardin L; Auclair AL; Depoortere R; Newman-Tancredi A
    Behav Pharmacol; 2008 Mar; 19(2):145-52. PubMed ID: 18332679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of serotonin-1A receptors in the action of antipsychotic drugs: comparison of prepulse inhibition studies in mice and rats and relevance for human pharmacology.
    Gogos A; Bogeski M; van den Buuse M
    Behav Pharmacol; 2008 Sep; 19(5-6):548-61. PubMed ID: 18690109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-acetyl-L-cysteine inhibits marble-burying behavior in mice.
    Egashira N; Shirakawa A; Abe M; Niki T; Mishima K; Iwasaki K; Oishi R; Fujiwara M
    J Pharmacol Sci; 2012; 119(1):97-101. PubMed ID: 22510519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 5-hydroxytryptamine 2A receptor agonists DOI and 25CN-NBOH decrease marble burying and reverse 8-OH-DPAT-induced deficit in spontaneous alternation.
    Odland AU; Jessen L; Kristensen JL; Fitzpatrick CM; Andreasen JT
    Neuropharmacology; 2021 Feb; 183():107838. PubMed ID: 31693871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of novel antipsychotics with mixed D(2) antagonist/5-HT(1A) agonist properties on PCP-induced social interaction deficits in the rat.
    Bruins Slot LA; Kleven MS; Newman-Tancredi A
    Neuropharmacology; 2005 Dec; 49(7):996-1006. PubMed ID: 16009387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of 5-hydroxytryptamine2C receptors in marble-burying behavior in mice.
    Egashira N; Okuno R; Shirakawa A; Nagao M; Mishima K; Iwasaki K; Oishi R; Fujiwara M
    Biol Pharm Bull; 2012; 35(3):376-9. PubMed ID: 22382324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of aripiprazole and ethanol attenuates marble-burying behavior in mice.
    Gaikwad U; Parle M
    Acta Pol Pharm; 2011; 68(3):435-40. PubMed ID: 21648199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin 5-HT
    Gener T; Tauste Campo A; Alemany-González M; Nebot P; Delgado-Sallent C; Chanovas J; Puig MV
    Neuropharmacology; 2019 Nov; 158():107743. PubMed ID: 31430459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perospirone, a novel antipsychotic agent, hyperpolarizes rat dorsal raphe neurons via 5-HT1A receptor.
    Shiwa T; Amano T; Matsubayashi H; Seki T; Sasa M; Sakai N
    J Pharmacol Sci; 2003 Sep; 93(1):114-7. PubMed ID: 14501160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 5-HT uptake inhibitors, agonists and antagonists on the burying of harmless objects by mice; a putative test for anxiolytic agents.
    Njung'e K; Handley SL
    Br J Pharmacol; 1991 Sep; 104(1):105-12. PubMed ID: 1686200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A combined marble burying-locomotor activity test in mice: a practical screening test with sensitivity to different classes of anxiolytics and antidepressants.
    Nicolas LB; Kolb Y; Prinssen EP
    Eur J Pharmacol; 2006 Oct; 547(1-3):106-15. PubMed ID: 16934246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of YM992, a novel antidepressant with selective serotonin re-uptake inhibitory and 5-HT 2A receptor antagonistic activity, on a marble-burying behavior test as an obsessive-compulsive disorder model.
    Takeuchi H; Yatsugi S; Yamaguchi T
    Jpn J Pharmacol; 2002 Oct; 90(2):197-200. PubMed ID: 12419892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.